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E-mail address: e.cuppen@niob.knaw.nl (E. CuppeRapid advances in DNA sequencing improve existing techniques and enable new approaches in
genetics and functional genomics, bringing about unprecedented coverage, resolution and sensitiv-
ity. Enhanced toolsets can facilitate the untangling of connections between genomic variation, envi-
ronmental factors and phenotypic effects, providing novel opportunities, but may also pose
challenges in data interpretation, especially in highly heterogeneous human populations. Labora-
tory rodent strains, however, offer a variety of tailored model systems with controlled genetic back-
grounds, facilitating complex genotype/phenotype relationship studies. In this review we discuss the
advent of massively parallel sequencing, its methodological advantage for molecular analysis in
model organisms and the expectation of increased understanding of biologically relevant conse-
quences of human genetic variation.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
With the advent of massively parallel sequencing technologies
[1,2], we are approaching the possibility of resequencing a human
genome for only $1000. As this price tag is comparable to that of
advanced clinical tests, genome sequencing may become a com-
mon diagnostic procedure. As a consequence, personal genomes
will mark a new era in biomedicine as medical records of patients
(or even those of healthy individuals) will expand to incorporate
data about millions of DNA variants. Still, our knowledge of how
these variants account for disease or disease susceptibility or
determine the success of different treatment strategies is
fragmentary.
A common way of obtaining the information linking genotypes
to speciﬁc phenotypes in humans is to perform genome-wide asso-
ciation studies (GWAS) in which whole-genome genetic informa-
tion, typically more than half a million polymorphisms, is
collected for thousands of patients and control cases, with the goal
of ﬁnding more than randomly expected correlations between a
genomic interval and the disease parameter being studied. Cur-
rently, over 150 such relationships have been found and their
number is growing rapidly [3]. Although many monogenetic disor-
ders have been successfully mapped and their causal variants iden-
tiﬁed, a more typical GWAS analysis for a complex trait results inchemical Societies. Published by E
n).the discovery of a number of genomic loci with modest effects that
collectively explain only a small part of the observed phenotypic
variation. Clearly, the detection of the complete genetic component
of a complex trait is hampered by the many rare genetic variants
that are present in the rapidly growing human population [4,5].
Although some of these variants may have deleterious effects
with respect to certain phenotypes, the majority are expected to
be non-functional. Finally, multiple variants may interact with
each other in an additive, neutralizing or complex manner. It is
thus a major challenge in human genetics to identify and function-
ally characterize relevant genetic variants and their contributions
to phenotypes.
Given the limits of clinical research in humans, cellular and
animal models can greatly aid in deciphering the mechanistic ef-
fects of genetic variants. To this end, murine models of human dis-
eases such as mouse and rat laboratory strains represent
convenient tools for the investigation of the functional effects of
genetic variation. These models are characterized by reduced ge-
netic complexity in a variety of experimental setups. In addition,
access to genetic and physiological manipulations makes them
an ideal platform for functional genomics research to study dis-
ease susceptibility and etiology, as well as testing of intervention
strategies.
While there are extensive discussions on the advance of
sequencing technologies [6] and how they may revolutionize stud-
ies in humans [7], we want to focus this review on the beneﬁts of
next-generation sequencing technologies in mammalian model
systems for functional genomics research.lsevier B.V. All rights reserved.
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The translation of a DNA variant into phenotypic differences be-
tween individuals is one of the central questions of the post-gen-
ome era. Several obstacles impede the progress of understanding
genotype–phenotype links in humans. First, the extensive genetic
heterogeneity of and heterozygosity in the human population,
which is intrinsic to its outbred nature, makes the investigation
of the effect(s) of a single isolated DNA variant extremely difﬁcult.
Given that the contribution of a single variant to a phenotype can
be rather small, these effects are likely to be missed in heteroge-
neous samples. Furthermore, invasive experiments are not com-
mon in human subjects and bioethical aspects often prevent the
disclosure of all of the patients’ data, which could be relevant for
statistical interpretation and classiﬁcation. Finally, the phenotypic
data (both of patients and control subjects) is often incomplete and
should be updated constantly and extended as people acquire dis-
eases with age.
Experimental genetic model systems such as laboratory mice
and rats may greatly facilitate the uncovering of general principles
that guide the translation of DNA variants into phenotypic differ-
ences seen among individuals [8]. For over 100 years, rodent mod-
els have provided a renewable source of laboratory animals that
model a wide variety of common human diseases [9]. They serve
as indispensable tools for genetic, physiological, behavioral, and
toxicological studies. The key advantages of these model systems
are:
(i) The possibility to perform experiments in a controlled envi-
ronment using individuals with a known genetic back-
ground. Inbred individuals exhibit homozygosity at every
locus, facilitating studies of recessive alleles. In addition, ani-
mals can be reared and studied under controlled laboratory
conditions.
(ii) Reproducibility of experiments. Since individual animals from
the same inbred line are genetically identical, experimental
results can be reproduced in completely independent exper-
iments, improving experiments in terms of both robustness
of results and sensitivity for discovery.
(iii) Cumulative nature of phenotype and genotype data. In the case
of model systems, any tissue is accessible and can be col-
lected at any developmental stage. In turn, the obtained
genotype and phenotype readouts should be invariant, given
the inbred nature of the strain.
(iv) Genome manipulation. Gene knock-out and knock-in technol-
ogies enable disrupting or altering gene structure and
expression in a targeted way. It is even possible to ‘human-
ize’ a model by introducing genetic variants that are similar
to the genetic lesions observed in human patients.
(v) Flexible modeling of human diseases and intervention strate-
gies. Since speciﬁc strains are selected for their susceptibility
to certain common diseases, these models can not only be
used for increasing our understanding of disease etiology
and biology, but are also well-suited for systematic testing
of physiological or pharmacological interventions.
1.2. The variety of murine models
There has been a historical split in murine models: the labora-
tory rat has been a primary model for physiological and pharmaco-
logical studies while the laboratory mouse has served as the most
popular mammalian genetic model, especially due to the availabil-
ity of targeted gene knockout technology. However, thanks to tech-
nological developments, experimental limitations in the rat are
rapidly disappearing. Current genetic model systems in mice andrats include a variety of experimental platforms tailored to the
identiﬁcation of genomic loci and genetic variants that contribute
to the disease of interest or inﬂuence disease susceptibility. Exam-
ples are classical inbred strains, recombinant inbred strains, out-
bred strains, heterogeneous stocks, consomic and congenic
strains, and gene-knockout models (Fig. 1). These strains include
a wide variety of physiological and phenotypic parameters, either
collected in small-scale dedicated experiments or large-scale sys-
tematic characterization studies, presenting a range of possibilities
for follow-up experiments.
Much effort has been put into the development and character-
ization of these genetic models. A good example of a popular sys-
tem in rat genetics is the HXB/BXH recombinant inbred (RI) panel
that represents a thoroughly characterized set of 30 rat strains that
resulted from the inbreeding of F2 animals from a BN-Lx  SHR
cross (reviewed in [10]). The development of this panel commenced
in 1982 and currently represents the largest set of recombinant
inbred rat strains. The RI panel as a model platform simpliﬁes asso-
ciation and linkage analysis while providing direct access to any of
the individual strains for experimental follow-up. Multiple animals
of each of the RI strains have been characterized for a wide variety
of phenotypic parameters, including cardiovascular, metabolic,
behavioral, developmental and toxicological traits, as well as
molecular markers such as gene-expression levels. Currently, there
are hundreds of phenotypic (pQTLs) and thousands of expression
quantitative trait loci (eQTLs) described for this panel.
Another type of model platform that can effectively mimic hu-
man heterozygosity is the heterogeneous stock (HS, Fig. 1) [11,12].
Heterogeneous stocks represent a deﬁned pool of genetic variation
derived from a limited number of inbred progenitor strains that are
outbred via pseudorandom breeding. As a result, heterogeneous
stocks provide diverse combination of alleles with deﬁned genetic
background and exploit historic recombinations that have accumu-
lated in a genetically heterogeneous population. Quantitative trait
loci (QTLs) can be mapped using HS strains, resulting in a high res-
olution with intervals of less than 1 cM. With eight inbred strains
that typically contribute to an HS panel, one can expect to ﬁnd
many more QTLs than in an RI panel. The success of QTL mapping
in HS mice [11,13] has inspired the development of similar re-
sources for other model organisms [12].
QTL mapping approaches in rodents have shown that for com-
plex human diseases such as hypertension, multiple QTLs can be
found throughout the genome. To dissect the contribution of a sin-
gle locus, multiple consomic and congenic strains have been con-
structed on the same genetic backgrounds as the RI or HS panels
(reviewed in [14]). These designer strains can be used for further
crosses to narrow down the QTL region and to help uncover
gene–gene interactions in complex diseases. Interestingly, QTL re-
gions identiﬁed in rodent studies often overlap with syntenic re-
gions in the human genomes that were identiﬁed in relevant
human QTL and GWAS studies.2. Prospects for next-generation sequencing
Recent advances in parallelization of DNA sequencing technol-
ogy and extensive increases in throughput are dramatically reduc-
ing the price and speed of sequencing. Sequencing of a mammalian
genome does not cost millions anymore and it is expected that
costs will drop below $5000 per genome by the end of 2009. Where
consortium efforts were required before, a single laboratory can
now afford to sequence their organism or strain of interest. The
advantage of cheap sequencing does not end here; many other
existing technologies are expected to adopt massively parallel
sequencing to attain better performance, resolution and speciﬁcity.
In this review, we aim to highlight the beneﬁts of next generation
Fig. 1. Various rodent model systems. The top panel illustrates the development of the HXB/BXH recombinant inbred panel in rats. The inbred strains BN-Lx and SHR were
crossed and hybrid F1 animals were intercrossed to generate mosaic F2 animals. Individual RI lines were derived by backcrosses for over 80 generations. The middle panel
outlines consomic and congenic strains where a chromosome or a single locus from one strain was replaced by the same segment taken from another strain. The bottom panel
explains the composition of heterogeneous stocks using the rat HS panel as an example.
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model systems.
2.1. Model genomes: more genomes with less effort
The availability of multiple genomes can greatly advance the
ﬁeld of comparative and functional genomics. A good example is
the effort to generate genome assemblies of twelve different Dro-
sophila species [15] that concluded in 2007 and inspired many fol-
low-up studies. At present, with several high-throughput
sequencing runs it is already possible to perform whole-genome
resequencing and polymorphism discovery for model organisms
with relatively small genomes like Caenorhabditis elegans [16]. As
the instruments improve, the read coverage obtained in a single
run will be sufﬁcient to decipher complete mammalian genomes.
Complete resequencing of model organisms has a better poten-
tial for early adoption than large scale resequencing of human gen-
omes as it can deliver more information with less money and
effort. Since the breeding history of rodent genetic model systems
is known, it is sufﬁcient to resequence only a handful of parentalstrains to capture all variation in the complete model system. Be-
cause of the inbred nature of parental strains, haplotypes should
not interfere with the phasing or genome assembly process. Once
parental genomes are well-characterized, relatively simple and
inexpensive genotyping can be used to determine the genetic com-
position of all the derived strains.
Another advantage of using model systems is that sequencing of
several strains will result in a complete inventory of all sequence
variants. This is in contrast to human studies where, because of
rare alleles, obtaining all sequence variants requires full rese-
quencing of all samples. NGS approaches provide the opportunity
to rapidly characterize the complete ‘variome’ in mammalian mod-
el systems, thereby ensuring that no variants with potential phe-
notypic effects are left behind.
2.2. DNA variation discovery and contribution to genetic studies
But what would these additional complete genomes mean for
model organisms’ genetics? First of all, they will provide a detailed,
high-resolution genetic map for forward genetics approaches. With
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mutation mapping is, to a great degree, limited by the density of
known markers. Even mild resequencing of different strains can
signiﬁcantly improve their genetic maps and increase the precision
of QTL or mutation mapping. The new sequencing technologies
may enhance the mutation mapping procedure in yet another
way: regions of interest can be captured on microarray slides
and resequenced to perform ﬁne mapping or mutation discovery
[18–20].
Further, with even more sequencing throughput, it will be pos-
sible to resequence a full genome of a speciﬁc strain to identify the
causal variant or variants. Although identiﬁcation of a ‘causal’
mutation solely by sequencing is not feasible yet [21], further
improvements in the accuracy and length of sequencing reads
are expected to improve this situation, although some degree of
outcrossing or mapping will remain needed.
Beyond sequencing different strains or isolates of the same
organism, closely related taxa can be sampled to study phyloge-
nomics, or the evolutionary history of model organisms. Additional
genomes will not only highlight recent selection events, but should
also facilitate better alignments, gene predictions and identiﬁca-
tion and analysis of functionally important noncoding regions such
as promoters [22].
2.3. Structural genome variation
Another class of genomic variation that has only recently been
appreciated is structural variation [23]. Change in copy-number
of genomic segments is implicated in many human genetic disor-
ders and is estimated to account for about 20% of gene expression
differences between individuals [24]. In contrast to variation due
to copy-number, current genome-wide methods of choice, such
as array-based comparative genome hybridization, cannot cope
with detection of copy-neutral structural variants such as inver-
sions and translocations, and cannot distinguish tandem from
non-tandem duplications. However, these types of variants can
effectively be discovered and detected using paired-end mapping
(PEM) technology, which is available for all three commonly used
next-generation sequencing platforms present on the market. With
paired-end mapping facilitated by next-generation sequencing, it
becomes in principle possible to characterize copy-number and
copy-neutral structural variations at the base-pair level [25]. Nev-
ertheless, the combination of PEM and NGS requires sophisticated
data analysis for interpretation of genome structure alterations. As
the effect of structural genome variation on phenotypic diversity
remains largely unexplored, genetic model systems may play an
important role in untangling these relationships in a systematic
way.
2.4. Assembling genomes de novo
Affordable sequencing will not only change our approach to
model systems, it will also dramatically change the model systems
as we know them. Many organisms have unique features, but lack
the genomic characterization that stems from advances such as
genome assembly. Last year, the feasibility of de novo genome
assembly using short reads was demonstrated for bacterial gen-
omes [26,27] and we can expect that de novo assemblies of more
complex genomes will follow. While good reference genomes are
available for both mouse and rat, resequencing additional strains
will require some degree of de novo assembly as well, as genomic
segments that are lacking in a reference genome are not automat-
ically included in de novo assemblies based on short read-based
shotgun resequencing. Reads that cannot be mapped to the refer-
ence genome could represent strain-speciﬁc genomic sequence.
De novo assembly of mammalian genome sequences using shortreads remains bioinformatically challenging. In addition, such ef-
forts are further complicated by the fact that the pool of unmappa-
ble reads includes poor quality reads. However, with increased
read lengths and quality due to technological improvements, these
complications are expected to disappear.
Finally, next-generation sequencing is also expected to contrib-
ute to the functional annotation of the available or newly assem-
bled genomes. Resequencing of the transcribed component of a
genome, as discussed below, will improve our understanding of
functionally relevant regions in genomes.
2.5. Complete transcriptomes
Undoubtedly, one of the most anticipated applications of NGS is
high-throughput sequencing of RNA samples, known as RNA-Seq.
RNA-Seq has been shown to be an exhaustive and reproducible
method of mRNA expression proﬁling [28–30]. Direct and truly
quantitative, it detects not only unknown transcripts, but also tran-
script isoforms, providing unprecedented experimental evidence
for the expression of predicted genes and non-coding transcripts
as well as previously unknown splice forms of known transcripts.
The complexity, dynamics and sequence context of transcriptomes
can now in principle be studied in a near-complete fashion in a sin-
gle experimental approach.
Early studies in this area have revealed many unexpected tran-
script structures, and it is evident that, even in carefully designed
microarray-based studies, a substantial fraction of RNA molecules
have escaped detection. RNA-Seq effectively combines the discov-
ery of transcript structures and proﬁling of their expression and
can be employed for the ab initio construction of complex mamma-
lian transcriptomes [31].
RNA-Seq opens a wide range of scientiﬁc questions that can be
explored in model systems. First, this complete and robust expres-
sion proﬁling can be done for multiple tissues and at different
(including preclinical) stages of disease progression. Secondly,
due to the complexity of the regulation network, the effect of ge-
netic variation in a single locus can be addressed in a simpliﬁed
system such as a congenic strain. Furthermore, it is of interest to
investigate what major factors are driving differential gene expres-
sion in mammals. To reveal the genetic components in mRNA
expression, a survey of allele-speciﬁc expression of mammalian
transcriptomes can be employed. By looking at allelic imbalance
in an F1 intercross of two genetically dissimilar strains, cis-regula-
tion of genes can be studied [32]. Scaling this method to use mas-
sively parallel sequencing in combination with model system such
as heterogeneous stocks may become a unique and powerful ap-
proach. While genome-wide application of this method requires
at least one polymorphism in every transcript, a recent study
showed that intronic SNPs might be informative for assessing allele
imbalance [33].
Finally, the potential to manipulate these genetic model sys-
tems can be used to explore the inﬂuence of tissue-, sex-, age-,
and environment-speciﬁc factors on transcription, and holds the
key to the comprehensive understanding of expression regulation
under variable conditions.
The comparative analysis of genotypic data and gene expression
results can be used for the discovery of eQTLs that link expression
changes to genomic segments with correlated strain distribution
patterns (SDPs). Cis-eQTLs, genomic segments localized to the
transcripts, are thought to represent promoter regulatory variants
or alleles that affect transcript processing or stability. At the same
time, far more trans-eQTLs are observed, which typically have a
smaller effect on transcript expression. Expression proﬁling using
microarrays (e.g. Affymetrix RAE230 for BXH/HXB rats) has already
revealed hundreds of robust links between DNA polymorphisms
and expression changes [34]. Another challenge for eQTL studies
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SDPs throughout the genome, some of which may correlate with
expression when the number of strains is limited [34]. RNA
sequencing is likely to boost the number and speciﬁcity of such
discoveries as increased sensitivity improves the detection of
low-level expression, enabling better monitoring of more subtle
expression changes.
While traditional eQTL studies compare the quantitative effect
of genetic variation on gene expression, RNA-Seq provides means
to perform these studies in a qualitative manner. In other words,
it enables the discovery of genetic variants that affect alternative
transcript initiation, splicing and termination, so called splice QTLs
(sQTLs) [35]. The correlation between an expressed splice isoform
and its genomic locus in RI and HS panels can reveal polymor-
phisms critical for splicing: cis-sQTLs and polymorphic genes that
encode splice-factors, trans-sQTLs.
2.6. Mapping the epigenome and protein–DNA interactions
Massive sequencing is rapidly emerging as a powerful tool in
sequence census methods [36]. In recent years, extensive chroma-
tin modiﬁcation and protein binding data have been generated by
chromatin immunoprecipitation coupled with microarray hybrid-
ization (ChIP-chip). The use of sequencing as a substitute for
microarrays (ChIP-Seq) has improved the method in several ways
[37–40]. First, direct sequencing is data ‘agnostic’ and can address
a larger part of the genome (though not the entire genome) in vir-
tual absence of a cross-hybridization background bias. Secondly, it
can achieve a level of base-pair resolution that allows more precise
mapping of protein binding or DNA/chromatin modiﬁcation sites.
A recent study was able to determine the binding sites of the NRSF
(neuron-restrictive silencer factor) and GABP (growth associated
binding protein) transcription factors with a resolution of 20 bp
and a mean distance between peak call and putative motif of just
several base pairs [37]. The unprecedented sensitivity of the meth-
od also enables researchers to reveal binding sites of cofactor pro-
teins. Another advantage of the new method is digital proﬁling of
binding/modiﬁcation events. Since this method counts the number
of reads, it is not biased by the hybridization dynamics of micro-
array-based experiments. ChIP-Seq does not have the problem of
continuous hybridization signal (and saturation) and thus has a
greater dynamic resolution compared to ChIP-chip (Fig. 2). Fur-
thermore, the direct reading of DNA expands regional information
to include allele-speciﬁc coverage, enabling the study of the effect
of genetic variation on factor binding or epigenetic modiﬁcation
[37]. Finally, since in most cases a given factor of interest occupiesFig. 2. Comparison of ChIP-chip and Chip-Seq sensitivity and resolution. The panels s
logarithmic ratio (base 2) for the hybridization intensity ratio between ChIP and input DN
(bottom) are shown. The arrow below the ChIP-Seq panel shows the position of the Tcf4
SOLiD sequencing, shows sharper and more structured peaks with greater dynamic ranonly small parts of the genome, sequencing saturation is already
relatively rapidly achieved, making ChIP-Seq a ﬁnancially attrac-
tive alternative to ChIP-chip.
These technological beneﬁts of sequencing analysis increase the
diversity of substrates that can be detected to include transcription
factors, nucleosome cores, DNA methylation and histone modiﬁca-
tions. A recent comprehensive analysis of 20 different histone
modiﬁcations has revealed their genome-wide distribution pattern
[38]. These epigenetic markers differentially mark active promot-
ers, transcription start sites, and gene bodies, information that is
highly complementary to RNA-Seq results. By employing this
method, it has become possible to discern epigenetic changes that
distinguish pluripotent from lineage-committed cells [39].
ChIP-Seq is highly complementary to expression proﬁling
experiments, and is a superior method for untangling the mecha-
nistic changes that lead to differential gene expression, for exam-
ple when normal and diseased tissues are compared. However,
the testing of interventions that can reverse epigenetic and regula-
tory changes back to a healthy state (e.g. using inducible systems)
is limited to model animal or cell systems. In these systems, the
transition between different regulatory states can be monitored
in any tissue type and followed throughout all developmental
stages. Although we are aware of the interplay between both ge-
netic and environmental factors affecting the epigenetic state of
chromatin, the use of inbred animals, where the genetic compo-
nent can be ﬁxed, can provide the proper tools to study the inﬂu-
ence of isolated environmental factors such as diet, age and
disease progression on gene switching.
2.7. Spatial organization of the genome
It is known that the organization of chromatin in the nucleus is
highly nonrandom and that the relative location of regulatory
modules is critical for gene expression. Several techniques have
been developed to discover the proximity of DNA segments at
both the local and genome-wide levels, reviewed in [40].
Although, to our knowledge, no studies have been published using
chromosome conformation capture with massive sequencing, the
analysis of genome organization can hugely beneﬁt from mas-
sive-scale sequencing. This combination of technologies may ulti-
mately develop into a method that reconstructs the complete
spatial organization of chromosomes in the nucleus [41]. Again,
we envision that model systems will provide major contributions,
from allowing simpliﬁed initial experiments to enabling more
ﬂexible and reproducible studies of conformational changes in dis-
ease models.how a comparison of technologies used for Tcf4 transcription factor binding. The
A for the ChIP-chip experiment (top) and read coverage for the ChIP-Seq experiment
binding site (WTCAAAG). The ChIP-Seq method, supplemented by massively parallel
ge and little background signal.
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studies and understanding of human genomic variation
This review has not described all of the potential utilizations of
ultra-high-throughput sequencing; many potential utilizations are
currently under development, including massive bisulﬁte sequenc-
ing, mapping of DNase hypersensitive sites, and more. It is appar-
ent, though, that affordable sequencing is rapidly changing our
experimental approaches and improving the completeness, resolu-
tion and sensitivity of their results.
Although the primary goal in biomedical research is to under-
stand human biology and disease etiology and susceptibility, one
should also realize that initially applying these large scale technol-
ogies to the genetically complex human system may generate a
puzzle that consists of so many pieces and potential solutions that
current statistical analysis approaches do not sufﬁce to ﬁnd the
correct and causal relation between a genetic event (or more likely
several events) and a phenotypic consequence. Applying the next-
generation sequencing-based tools mentioned above in a system-
atic and comprehensive way in a controlled genetic system, such
as a rodent RI or HS model system, enables the development of
both statistical linkage and association models at the nucleotide le-
vel and dynamic computational systems biological approaches to
describe gene-regulatory models and their genetic effects. Integra-
tion of these models with human linkage data, GWAS results, and,
in the near future, personal genomics information is expected to
provide a powerful approach towards a better understanding of
clinically relevant genotype–phenotype relationships. Ultimately,
this approach is also expected to provide novel strategies for phar-
macological interference.
As biology is often found to be much more complex than antic-
ipated, devoting sufﬁcient next-generation sequencing resources
to model organism applications is likely to pay off quickly by
increasing our understanding of the data that soon will be ﬂooding
in from thousands of human genome sequencing projects.
References
[1] Margulies, M. et al. (2005) Genome sequencing in microfabricated high-
density picolitre reactors. Nature 437, 376–380.
[2] Bentley, D.R. (2006) Whole-genome re-sequencing. Curr. Opin. Genet. Dev. 16,
545–552.
[3] Altshuler, D., Daly, M.J. and Lander, E.S. (2008) Genetic mapping in human
disease. Science 322, 881–888.
[4] Pritchard, J.K. (2001) Are rare variants responsible for susceptibility to
complex diseases? Am. J. Hum. Genet. 69, 124–137.
[5] Kryukov, G.V., Pennacchio, L.A. and Sunyaev, S.R. (2007) Most rare missense
alleles are deleterious in humans: implications for complex disease and
association studies. Am. J. Hum. Genet. 80, 727–739.
[6] Mardis, E.R. (2008) Next-generation DNA sequencing methods. Annu. Rev.
Genomics Hum. Genet. 9, 387–402.
[7] ten Bosch, J.R. and Grody, W.W. (2008) Keeping up with the next generation:
massively parallel sequencing in clinical diagnostics. J. Mol. Diagn. 10, 484–
492.
[8] Aitman, T.J. et al. (2008) Progress and prospects in rat genetics: a community
view. Nat. Genet. 40, 516–522.
[9] Moreno, C., Lazar, J., Jacob, H.J. and Kwitek, A.E. (2008) Comparative genomics
for detecting human disease genes. Adv. Genet. 60, 655–697.
[10] Printz, M.P., Jirout, M., Jaworski, R., Alemayehu, A. and Kren, V. (2003) Genetic
models in applied physiology. HXB/BXH rat recombinant inbred strain
platform: a newly enhanced tool for cardiovascular, behavioral, and
developmental genetics and genomics. J. Appl. Physiol. 94, 2510–2522.
[11] Valdar, W. et al. (2006) Genome-wide genetic association of complex traits in
heterogeneous stock mice. Nat. Genet. 38, 879–887.[12] Johannesson, M. et al. (2009) A resource for the simultaneous high-resolution
mapping of multiple quantitative trait loci in rats: the NIH heterogeneous
stock. Genome Res. 19, 150–158.
[13] Mott, R., Talbot, C.J., Turri, M.G., Collins, A.C. and Flint, J. (2000) A method for
ﬁne mapping quantitative trait loci in outbred animal stocks. Proc. Natl. Acad.
Sci. USA 97, 12649–12654.
[14] Kwitek-Black, A.E. and Jacob, H.J. (2001) The use of designer rats in the genetic
dissection of hypertension. Curr. Hypertens. Rep. 3, 12–18.
[15] Clark, A.G. et al. (2007) Evolution of genes and genomes on the Drosophila
phylogeny. Nature 450, 203–218.
[16] Hillier, L.W. et al. (2008) Whole-genome sequencing and variant discovery in
C. elegans. Nat. Meth. 5, 183–188.
[17] Saar, K. et al. (2008) SNP and haplotype mapping for genetic analysis in the rat.
Nat. Genet. 40, 560–566.
[18] Okou, D.T., Steinberg, K.M., Middle, C., Cutler, D.J., Albert, T.J. and Zwick, M.E.
(2007) Microarray-based genomic selection for high-throughput
resequencing. Nat. Meth. 4, 907–909.
[19] Albert, T.J. et al. (2007) Direct selection of human genomic loci by microarray
hybridization. Nat. Meth. 4, 903–905.
[20] Porreca, G.J. et al. (2007) Multiplex ampliﬁcation of large sets of human exons.
Nat. Meth. 4, 931–936.
[21] Shen, Y., Sarin, S., Liu, Y., Hobert, O. and Pe’er, I. (2008) Comparing platforms
for C. elegans mutant identiﬁcation using high-throughput whole-genome
sequencing. PLoS ONE 3, e4012.
[22] Boffelli, D., McAuliffe, J., Ovcharenko, D., Lewis, K.D., Ovcharenko, I., Pachter, L.
and Rubin, E.M. (2003) Phylogenetic shadowing of primate sequences to ﬁnd
functional regions of the human genome. Science 299, 1391–1394.
[23] Redon, R. et al. (2006) Global variation in copy number in the human genome.
Nature 444, 444–454.
[24] Stranger, B.E. et al. (2007) Relative impact of nucleotide and copy number
variation on gene expression phenotypes. Science 315, 848–853.
[25] Korbel, J.O. et al. (2007) Paired-end mapping reveals extensive structural
variation in the human genome. Science 318, 420–426.
[26] Reinhardt, J.A., Baltrus, D.A., Nishimura, M.T., Jeck, W.R., Jones, C.D. and Dangl,
J.L. (2009) De novo assembly using low-coverage short read sequence data
from the rice pathogen Pseudomonas syringae pv. oryzae. Genome Res. 19 (2),
294–305.
[27] Hernandez, D., Francois, P., Farinelli, L., Osteras, M. and Schrenzel, J. (2008) De
novo bacterial genome sequencing: millions of very short reads assembled on
a desktop computer. Genome Res. 18, 802–809.
[28] Weber, A.P., Weber, K.L., Carr, K., Wilkerson, C. and Ohlrogge, J.B. (2007)
Sampling the Arabidopsis transcriptome with massively parallel
pyrosequencing. Plant Physiol. 144, 32–42.
[29] Cloonan, N. and Grimmond, S.M. (2008) Transcriptome content and dynamics
at single-nucleotide resolution. Genome Biol. 9, 234.
[30] Mortazavi, A., Williams, B.A., McCue, K., Schaeffer, L. and Wold, B. (2008)
Mapping and quantifying mammalian transcriptomes by RNA-Seq. Nat. Meth.
5, 621–628.
[31] Yassour, M. et al. (2009) Ab initio construction of a eukaryotic transcriptome
by massively parallel mRNA sequencing. Proc. Natl. Acad. Sci. USA 106, 3264–
3269.
[32] Campbell, C.D., Kirby, A., Nemesh, J., Daly, M.J. and Hirschhorn, J.N. (2008) A
survey of allelic imbalance in F1 mice. Genome Res. 18, 555–563.
[33] Serre, D. et al. (2008) Differential allelic expression in the human genome: a
robust approach to identify genetic and epigenetic cis-acting mechanisms
regulating gene expression. PLoS Genet. 4, e1000006.
[34] Petretto, E. et al. (2006) Heritability and tissue speciﬁcity of expression
quantitative trait loci. PLoS Genet. 2, e172.
[35] Heinzen, E.L. et al. (2008) Tissue-speciﬁc genetic control of splicing:
implications for the study of complex traits. PLoS Biol. 6, 2869–2879.
[36] Wold, B. and Myers, R.M. (2008) Sequence census methods for functional
genomics. Nat. Meth. 5, 19–21.
[37] Valouev, A., Johnson, D.S., Sundquist, A., Medina, C., Anton, E., Batzoglou, S.,
Myers, R.M. and Sidow, A. (2008) Genome-wide analysis of transcription
factor binding sites based on ChIP-Seq data. Nat. Meth. 5, 829–834.
[38] Barski, A. et al. (2007) High-resolution proﬁling of histone methylations in the
human genome. Cell 129, 823–837.
[39] Mikkelsen, T.S. et al. (2007) Genome-wide maps of chromatin state in
pluripotent and lineage-committed cells. Nature 448, 553–560.
[40] Simonis, M., Kooren, J. and de Laat, W. (2007) An evaluation of 3C-based
methods to capture DNA interactions. Nat. Meth. 4, 895–901.
[41] Dostie, J. and Dekker, J. (2007) Mapping networks of physical interactions
between genomic elements using 5C technology. Nat. Protoc. 2, 988–1002.
